Gepubliceerd in:
29-02-2024 | REVIEW
Efficacy of Digital Mindfulness-Based Interventions for Repetitive Negative Thinking: A Systematic Review and Bibliometric Analysis
Auteurs: Juan Vargas-Nieto, Danilo Zambrano, Ignacio Montorio, Lina M. Sanabria
Gepubliceerd in: Mindfulness | Uitgave 3/2024
Log in om toegang te krijgenshare
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Abstract
Objectives
With the development of new digital technologies, the dissemination of digital mindfulness-based interventions (MBIs) has spread notably in recent years. However, questions remain about their empirical validity and their effectiveness and limitations in addressing clinically relevant mechanisms. We sought to examine the efficacy of self-administered digital MBIs for the treatment of repetitive negative thinking (RNT).
Method
Studies were identified from electronic databases of Web of Science (WoS), Scopus, PubMed, and ProQuest. Three reviewers independently scanned articles for inclusion and data extraction. Additional mindfulness and RNT research indicators were obtained through descriptive data visualization techniques using bibliometric analysis.
Results
Eleven RCTs and two pilot RCTs were included with a total of 4509 participants. At post-treatment, ten studies reported statistically significant improvements in the condition of the MBIs in measures of RNT compared to control with effect sizes ranging from small to large (d = 0.18;0.77), and three studies found no evidence of significant effects associated with digital MBIs. However, the poor quality of some of the findings given the risk of bias assessment means that these results should be interpreted with discretion.
Conclusions
Digital MBIs could be considered a promising alternative to decrease RNT and increase mindfulness skills compared to other active and passive control conditions. However, more studies with higher methodological quality, better-balanced samples, longer follow-ups, and a more rigorous evaluation of their possible adverse effects are required.
Preregistration
This study was retrospectively registered on PROSPERO (Ref No: CRD42023389700).
